PTGX: Protagonist Therapeutics O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati
Doimiy ortiqcha likvidlik va hamkorlik to'lovlari Protagonist Therapeutics (PTGX) kompaniyasiga moliyaviy barqarorlikni ta'minladi, bu esa foyda o'sishiga nisbatan P/E dinamikasida aks etgan. 0.00 qiymati ushbu ko'rsatkichning darajasini ifodalaydi. Muvaffaqiyat kompaniyaning oshqozon-ichak trakti va qon uchun peptid dori vositalarini ishlab chiqishdagi nufuzi, shuningdek, makroiqtisodiy inqirozlar yoki mavsumiylikdan himoyalangan biznes profiliga asoslangan.
Protagonist Therapeutics (PTGX) kompaniyasi koʻrsatkichlari kesimi va tahlili
- aksiya narxi va baholash bo'yicha konsensus prognoz:
- bozor kapitallashuvi haqida ma'lumot:
- kompaniyaning balans qiymati tafsilotlari:
- emitentning kredit yuki va likvidlik ko'rsatkichlari:
Umumiy qarzning kapitalga nisbati Protagonist Therapeutics|PTGX - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzning kapitalga nisbati ko'rsatkichi protagonist-inc.com|PTGX - Kompaniyaning jamlangan qarzlari|Balans qiymatiga qarzlar Protagonist Therapeutics Inc|PTGX - Kompaniyaning uzoq muddatli qarzi|Qisqa muddatli majburiyatlar Protagonist Therapeutics|Oraliq qoplash koeffitsiyenti protagonist-inc.com
- biznes foydasi va investitsiya koeffitsiyentlari ma'lumotlari:
PTGX - Kompaniyaning sof foydasi|Kutilayotgan sof foyda Protagonist Therapeutics|PTGX - Narx-foyda koeffitsiyenti|Kapitalizatsiyaning kelajakdagi foydaga nisbati Protagonist Corp|PTGX - PEG multiplikatori|EV/EBITDA multiplikatori Protagonist Therapeutics Inc|PTGX - EBITDA operatsion foydasi|Sirpanuvchi yil uchun bir aksiya uchun sof foyda Protagonist Therapeutics|PTGX - So'nggi o'n ikki oy davomida bir aksiya uchun foyda|So'nggi o'n ikki oy davomida yillik hisobda bir aksiya uchun foyda o'sishi protagonist-inc.com|PTGX - Joriy yilda bir aksiya uchun foyda o'sishi|Keyingi yil uchun bir aksiya uchun foydaning prognoz qilingan o'sish sur'ati Protagonist Therapeutics
Kompaniyaning umumiy tahlili:PTGX - Protagonist Therapeutics, Inc.
Sog'liqni saqlash gigantlari bilan hamkorlikda noyob peptid terapiyasi platformasini ishlab chiqayotgan Protagonist Therapeutics (PTGX) uchun ushbu ko'rsatkich biznes kengayish sur'atiga nisbatan bozor qiymatining adolatli ekanligini belgilaydi. Baholashning foyda o'sishiga nisbati ko'rsatkichini tahlil qilish orqali investor joriy P/E ko'rsatkichini daromad o'sish sur'atlari bilan solishtiradi: birdan past qiymatlar aktivning qadrsizlanganligini anglatadi, bu esa chegirma holatini saqlagan holda potentsial portlovchi o'sishni aniqlash imkonini beradi.
Protagonist Therapeutics raqobatchilari
ARGX (argenx N.V.) - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|PEG multiplikatori BNTX (BioNTech Group)|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati Abivax (ABVX)|ADMA - Narxning foydaga va o‘sish sur’atiga nisbati|immunovant.com (IMVT) - Narx-foyda va o‘sish multiplikatori|Kiniksa (KNSA) - Narxning foydaga va o‘sish sur’atiga nisbati|Narx-foyda va o‘sish multiplikatori Grifols SA|Narx-foyda va o‘sish multiplikatori ADPT|PEG multiplikatori Celldex Corp|Narxning foydaga va o‘sish sur’atiga nisbati Aurinia Pharmaceuticals (AUPH)|biocryst.com - O‘sishni hisobga olgan narx-foyda koeffitsiyenti|PEG multiplikatori VERA (Vera Therapeutics)|Dianthus Therapeutics Inc (DNTH) - O‘sish sur’atiga tuzatilgan narx-foyda|PHVS - Narxning foydaga va o‘sish sur’atiga nisbati|Kapitalizatsiyaning foyda va o‘sish sur’atiga nisbati ABCL|Tourmaline Bio, Inc. (TRML) - Narxning foydaga va o‘sish sur’atiga nisbati|precigen.com - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|Narxning foydaga va o‘sish sur’atiga nisbati Pharming Group|O‘sish sur’atiga tuzatilgan narx-foyda Nektar Therapeutics Inc NKTR|Narx-foyda va o‘sish multiplikatori UPB (Upstream Bio Corp)|Kompaniya qiymatining foyda o‘sish sur’atiga nisbati ZBIO|PEG multiplikatori IMNM (Immunome, Inc.)|PEG multiplikatori gossamerbio.com GOSS|KalVista Pharmaceuticals, Inc. - PEG multiplikatori|Narxning sof foyda o‘sishiga nisbati Septerna, Inc. (SEPN)|Pieris Pharmaceuticals Inc (PVLA) - Narxning foydaga va o‘sish sur’atiga nisbati|O‘sish sur’atiga tuzatilgan narx-foyda Savara Pharma (SVRA)|Narxning foydaga va o‘sish sur’atiga nisbati Rigel Pharmaceuticals|O‘sishni hisobga olgan narx-foyda koeffitsiyenti ANAB (anaptysbio.com)|PEG multiplikatori ATXS|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati enGene Holdings Inc|Narxning foydaga va o‘sish sur’atiga nisbati RAPT Therapeutics, Inc. RAPT|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati Aerovate Therapeutics, Inc. (JBIO)|ACRS: Narx-foyda va o‘sish multiplikatori|kyvernatx.com - Kompaniya qiymatining foyda o‘sish sur’atiga nisbati|TLSA (Tiziana Life Sciences Ltd) - Narx-foyda va o‘sish multiplikatori|Cabaletta Bio Inc. - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|Narx-foyda va o‘sish multiplikatori VTYX|THTX (Theratechnologies, Inc) - Kompaniya qiymatining foyda o‘sish sur’atiga nisbati|PEG multiplikatori AVTX|ELDN (eledon.com) - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|PEG multiplikatori AGEN (Agenus Inc.)|Climb Bio Inc. (CLYM) - O‘sish sur’atiga tuzatilgan narx-foyda|ZURA - Narxning foydaga va o‘sish sur’atiga nisbati|O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti ATYR (aTyr Pharmaceuticals)|ADAG: PEG multiplikatori|Ikena Oncology (IMA) - PEG multiplikatori|Narxning foydaga va o‘sish sur’atiga nisbati Shattuck Labs Inc|Equillium Bio - Kapitalizatsiyaning foyda va o‘sish sur’atiga nisbati|PEG multiplikatori CNTB|IMUX - O‘sish sur’atiga tuzatilgan narx-foyda|Atara Bio - Narx-foyda va o‘sish multiplikatori|PEG multiplikatori InflaRx NV IFRX|XFOR: Narx-foyda va o‘sish multiplikatori|Adicet Bio - Kompaniya qiymatining foyda o‘sish sur’atiga nisbati|CELU: PEG multiplikatori|INMB - O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati|BRNS (Barinthus Biotherapeutics) - PEG multiplikatori|Narx-foyda va o‘sish multiplikatori kezarlifesciences.com (KZR)|Narxning foydaga va o‘sish sur’atiga nisbati SAB Biotherapeutics, Inc. (SABS)|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati Akari Therapeutics PLC|Narxning foydaga va o‘sish sur’atiga nisbati Enlivex Therapeutics Ltd. ENLV|QTTB (Q32 Bio Inc) - Kapitalizatsiyaning foyda va o‘sish sur’atiga nisbati|GOVX: Narx-foyda va o‘sish multiplikatori|edesabiotech.com - Kompaniya qiymatining foyda o‘sish sur’atiga nisbati|IBIO: PEG multiplikatori|Narxning sof foyda o‘sishiga nisbati Carisma Therapeutics Inc. CARM|Narx-foyda va o‘sish multiplikatori XTLB|O‘sishni hisobga olgan narx-foyda koeffitsiyenti BOLT (Bolt Bio)|Narxning foydaga va o‘sish sur’atiga nisbati HCW Biologics Inc. (HCWB)|APVO: Kapitalizatsiyaning foyda va o‘sish sur’atiga nisbati|PEG multiplikatori AIM (AIM ImmunoTech)|O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti ADTX|GRI Bio Corp - PEG multiplikatori|XRTX - PEG multiplikatori|Vyome Holdings Inc (HIND) - Narxning foydaga va o‘sish sur’atiga nisbati|revbiosciences.com - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|Narxning foydaga va o‘sish sur’atiga nisbati Indaptus Therapeutics, Inc.|Narx-foyda va o‘sish multiplikatori Scinai Immunotherapeutics Ltd (SCNI)|PEG multiplikatori CALI|PEG multiplikatori affimed.com (AFMD)|Allakos - Narx-foyda va o‘sish multiplikatori|O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti HOOK|IGM Bio - PEG multiplikatori|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati iTeos Therapeutics Inc ITOS|Ocean Bio (OCEA) - Narxning foydaga va o‘sish sur’atiga nisbati|Narx-foyda va o‘sish multiplikatori TC BioPharm Ltd|Narxning foydaga va o‘sish sur’atiga nisbati Third Harmonic Bio
